Impel Pharmaceuticals Inc.

Impel Pharmaceuticals Inc. is a commercial stage pharmaceutical company focused on developing and providing transformative therapies that unlock the full potential of therapeutic molecules for people suffering from diseases with high unmet medical needs, with an initial focus on the central nervous system. Impel Pharmaceuticals is the first company to investigate targeting the upper nasal space with optimized therapeutic molecules and formulations for treating CNS diseases. As a result, Impel Pharmaceuticals’ therapies have the potential to improve the onset of symptomatic relief for a spectrum of neurological conditions. Today, Impel Pharmaceuticals is commercializing and providing treatments that use this gateway to deliver therapies for patients living with CNS diseases with high unmet medical needs.